Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: J Immunol. 2013 Aug 16;191(6):3082–3089. doi: 10.4049/jimmunol.1300830

Figure 6. Proposed model for CTLA4Ig.

Figure 6

Binding of CTLA4Ig to CD80/CD86 expressed on an antigen presenting cell can prevent naïve T cell activation by preventing CD28 mediated costimulation (left panel). In addition, CTLA4Ig can suppress the proliferation of activated effector T cells (Teff) through a TGFβ and Treg dependent mechanism that is independent of CD28-costimulation (right panel). This pathway requires and is synergistic with macrophage derived NO.